Research Funded To Date

PERFORM IN DEPTH MOLECULAR CHARACTERIZATION OF CLINICAL SAMPLES TO THE SINGLE CELL LEVEL AND ASSESS THE EFFECTS OF TREATMENT ON CELLULAR AND MOLECULAR HETEROGENEITY BEFORE AND DURING TREATMENT.

PIs: Paul Mischel, M.D.
Professor, Pathology and Laboratory Medicine
University of California Los Angeles (UCLA) School of Medicine

Timothy Cloughesy, M.D.
Director, Neuro-Oncology Program
University of California Los Angeles (UCLA) School of Medicine

James R. Heath, Ph.D.
Elizabeth W. Gilloon Professor
California Institute of Technology

Award: $2,250,000 over three years


DEVELOPMENT OF A NEURO-ONCOLOGY IMAGING PROGRAM USING MRI-PET AND MOLECULAR PROBES FOR IMPROVING THE MANAGEMENT OF GLIOMA.

PI: Sanjiv Sam Gambhir, M.D., Ph.D.
Head of Radiology and Nuclear Medicine Program
Stanford University

Award: $10,000,000 over five years


OUTLIERS IN GLIOBLASTOMA OUTCOME. DEEP GENOMIC ANALYSIS OF SHORT-TERM AND LONG-TERM SURVIVORS OF GBM TO UNDERSTAND THE MOLECULAR BASIS OF RESPONSE TO THERAPY AND TO GUIDE NEW TREATMENT DEVELOPMENT.

PI: Jeffrey M. Trent, Ph.D.
President and Scientific Director
Translational Genomics Research Institute (TGen)

Award: $5,000,000 over five years